Carregant...
Risk of Alzheimer’s Disease Among Senior Medicare Beneficiaries Treated With Androgen Deprivation Therapy for Prostate Cancer
PURPOSE: To assess the relative risk of Alzheimer’s disease (AD) among patients with prostate cancer who received androgen deprivation therapy (ADT), after adjustment for other cancer therapies. METHODS: Data from demographics, survival, diagnoses codes, procedure codes, and other information about...
Guardat en:
| Publicat a: | J Clin Oncol |
|---|---|
| Autors principals: | , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
American Society of Clinical Oncology
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5648173/ https://ncbi.nlm.nih.gov/pubmed/28841388 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2017.72.6109 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|